Open main menu

Psychiatrienet β

Difference between revisions of "Duloxetine-bupropion"

 
(5 intermediate revisions by 3 users not shown)
Line 3: Line 3:
 
| to = bupropion  
 
| to = bupropion  
 
| stop =  
 
| stop =  
* '''Day 0:''' gradually reduce dosage of duloxetine to a maximum of 60 mg/ day.
+
{{stopDuloxetine}}
* '''Day 1:''' reduce to a dosage of 30 mg/day.
 
 
| start =   
 
| start =   
 
* '''Day 1:''' simultaneously start bupropion in a normal dosage of 150 mg/day.
 
* '''Day 1:''' simultaneously start bupropion in a normal dosage of 150 mg/day.
* '''Day 8:''' stop administration of duloxetine and continue with bupropion only. }}
+
* '''Day 8:''' stop administration of duloxetine and continue bupropion.
 +
}}

Latest revision as of 11:28, 4 November 2015

Duloxetine
Type Antidepressant
Group SNRI
links
Medscape Duloxetine
PubChem 60835
PubMed Duloxetine
Kompas (Dutch) Duloxetine
Wikipedia Duloxetine
Bupropion
Type Antidepressant
Group other
links
ATC-code N06AX12
Medscape Bupropion
PubChem 444
PubMed Bupropion
Kompas (Dutch) Bupropion
Wikipedia Bupropion

Switch medication from duloxetine to bupropion.[1] [2]

Nietinrijdenbord.png Stop duloxetine
  • Before day 1: gradually reduce dosage of duloxetine to a maximum of 60 mg/ day, when this dosage is > 60 mg/day.
  • Day 1: reduce dosage of duloxetine to a maximum of 30 mg/day.
  • Day 8: stop administration of duloxetine.
Eenrichtingbord.png Start bupropion
  • Day 1: simultaneously start bupropion in a normal dosage of 150 mg/day.
  • Day 8: stop administration of duloxetine and continue bupropion.


  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.